Nucleoprotein-specific nonneutralizing antibodies speed up LCMV elimination independently of complement and FcγR. (Q39142065)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23749409%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

title

Nucleoprotein-specific nonneutralizing antibodies speed up LCMV elimination independently of complement and FcγR (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23749409%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23749409%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Ari Waisman

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23749409%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

author name string

Tobias Straub

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23749409%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Oliver Schweier

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23749409%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Michael Bruns

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23749409%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Hanspeter Pircher

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23749409%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

language of work or name

English

0 references

publication date

15 July 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23749409%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

2 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23749409%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23749409%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23749409%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

page(s)

2338-2348

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23749409%20AND%20SRC:MED&resulttype=core&format=json

CD8 T cell memory in B cell-deficient mice

2 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343565

Immunity to viruses in B cell-deficient mice: influence of antibodies on virus persistence and on T cell memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343565

Deficient CD4+ T cell priming and regression of CD8+ T cell functionality in virus-infected mice lacking a normal B cell compartment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343565

A critical role for neutralizing-antibody-producing B cells, CD4(+) T cells, and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: implications for adoptive immunotherapy of virus carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343565

B cells are crucial for both development and maintenance of the splenic marginal zone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343565

Type 1 IFN deficiency in the absence of normal splenic architecture during lymphocytic choriomeningitis virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343565

Impaired antibody response causes persistence of prototypic T cell-contained virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343565

OX40 facilitates control of a persistent virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343565

Late interleukin-6 escalates T follicular helper cell responses and controls a chronic viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343565

Toll-like receptor 7 is required for effective adaptive immune responses that prevent persistent virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343565

Early antibodies specific for the neutralizing epitope on the receptor binding subunit of the lymphocytic choriomeningitis virus glycoprotein fail to neutralize the virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343565

Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343565

IgG1 B cell receptor signaling is inhibited by CD22 and promotes the development of B cells whose survival is less dependent on Ig alpha/beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343565

Regulation of antinucleoprotein IgG by systemic vaccination and its effect on influenza virus clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343565

A crucial role for infected-cell/antibody immune complexes in the enhancement of endogenous antiviral immunity by short passive immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343565

Rectification of age-associated deficiency in cytotoxic T cell response to influenza A virus by immunization with immune complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343565

Immunodominance of an antiviral cytotoxic T cell response is shaped by the kinetics of viral protein expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343565

Lymphocytic choriomeningitis virus. X. Demonstration of nucleoprotein on the surface of infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343565

A novel role for non-neutralizing antibodies against nucleoprotein in facilitating resistance to influenza virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343565

Contributions of antinucleoprotein IgG to heterosubtypic immunity against influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343565

Early presence of ribonucleoprotein antigen on surface of influenza virus-infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343565

Nonneutralizing antibodies binding to the surface glycoprotein of lymphocytic choriomeningitis virus reduce early virus spread.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343565

Neutralizing (54K) and non-neutralizing (54K and 48K) monoclonal antibodies against structural and non-structural yellow fever virus proteins confer immunity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343565

Protection of C58 mice from lactate dehydrogenase-elevating virus-induced motor neuron disease by non-neutralizing antiviral antibodies without interference with virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343565

Synergistic Interactions of Anti-NS1 Monoclonal Antibodies Protect Passively Immunized Mice from Lethal Challenge with Dengue 2 Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343565

Biochemical and biological characteristics of epitopes on the E1 glycoprotein of western equine encephalitis virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343565

Treatment of influenza virus-infected SCID mice with nonneutralizing antibodies specific for the transmembrane proteins matrix 2 and neuraminidase reduces the pulmonary virus titer but fails to clear the infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343565

Multiple vaccine-elicited nonneutralizing antienvelope antibody activities contribute to protective efficacy by reducing both acute and chronic viremia following simian/human immunodeficiency virus SHIV89.6P challenge in rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343565

Antiviral antibody reacting on the plasma membrane alters measles virus expression inside the cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343565

Universal vaccine based on ectodomain of matrix protein 2 of influenza A: Fc receptors and alveolar macrophages mediate protection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343565

Long-lasting protective antiviral immunity induced by passive immunotherapies requires both neutralizing and effector functions of the administered monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343565

Poorly neutralizing cross-reactive antibodies against the fusion loop of West Nile virus envelope protein protect in vivo via Fcgamma receptor and complement-dependent effector mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343565

Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343565

Non-neutralizing antibodies protect from chronic LCMV infection independently of activating FcγR or complement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343565

Immune-correlates analysis of an HIV-1 vaccine efficacy trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343565

FcR gamma chain deletion results in pleiotrophic effector cell defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343565

Inhibitory Fcγ receptor engagement drives adjuvant and anti-tumor activities of agonistic CD40 antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343565

Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343565

Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343565

Lymphocytic choriomeningitis virus. VI. Isolation of a glycoprotein mediating neutralization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343565

Non-neutralizing monoclonal antibodies can prevent lethal alphavirus encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343565

Lysis of infected cells in vivo by antiviral cytolytic T cells demonstrated by release of cell internal viral proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343565

7 January 2021

Resistance of lymphocytic choriomeningitis virus to alpha/beta interferon and to gamma interferon

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343565

7 January 2021

Monoclonal antibodies to lymphocytic choriomeningitis and pichinde viruses: Generation, characterization, and cross-reactivity with other arenaviruses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343565

7 January 2021

Semliki Forest virus E2 envelope epitopes induce a nonneutralizing humoral response which protects mice against lethal challenge

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343565

7 January 2021

Use of monoclonal antibodies for analysis of antibody-dependent immunity to ocular herpes simplex virus type 1 infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343565

7 January 2021

Protective anti-reovirus monoclonal antibodies and their effects on viral pathogenesis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343565

7 January 2021

Antibody-mediated clearance of alphavirus infection from neurons

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343565

7 January 2021

Interactions between immune cells and antibody in protection from fatal Sindbis virus encephalitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343565

7 January 2021

Protection against lethal viral infection by neutralizing and nonneutralizing monoclonal antibodies: distinct mechanisms of action in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343565

7 January 2021

Role of complement and the Fc portion of immunoglobulin G in immunity to Venezuelan equine encephalomyelitis virus infection with glycoprotein-specific monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343565

7 January 2021